Biocryst Pharmaceuticals Stock Technical Analysis
| BCRX Stock | USD 7.53 0.07 0.92% |
As of the 16th of December 2024, BioCryst Pharmaceuticals shows the Risk Adjusted Performance of 0.0099, mean deviation of 2.33, and Downside Deviation of 3.63. BioCryst Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
BioCryst Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioCryst, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioCrystBioCryst |
BioCryst Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 15.2 | Strong Buy | 11 | Odds |
Most BioCryst analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BioCryst stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BioCryst Pharmaceuticals, talking to its executives and customers, or listening to BioCryst conference calls.
BioCryst Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioCryst Pharmaceuticals Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioCryst Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
BioCryst Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for BioCryst Pharmaceuticals. You can use it to identify possible trend reversals for BioCryst Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BioCryst Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.BioCryst Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for BioCryst Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.0009 , which may suggest that BioCryst Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.03, which is the sum of squared deviations for the predicted BioCryst Pharmaceuticals price change compared to its average price change.About BioCryst Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioCryst Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioCryst Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioCryst Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding BioCryst Pharmaceuticals. By analyzing BioCryst Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioCryst Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioCryst Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 12.48 | 15.3 | 7.93 | 6.31 | Receivables Turnover | 5.34 | 5.35 | 5.82 | 2.98 |
BioCryst Pharmaceuticals December 16, 2024 Technical Indicators
Most technical analysis of BioCryst help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioCryst from various momentum indicators to cycle indicators. When you analyze BioCryst charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0099 | |||
| Market Risk Adjusted Performance | 0.0099 | |||
| Mean Deviation | 2.33 | |||
| Semi Deviation | 3.45 | |||
| Downside Deviation | 3.63 | |||
| Coefficient Of Variation | 33757.32 | |||
| Standard Deviation | 3.27 | |||
| Variance | 10.7 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.0001) | |||
| Maximum Drawdown | 18.53 | |||
| Value At Risk | (4.34) | |||
| Potential Upside | 5.27 | |||
| Downside Variance | 13.19 | |||
| Semi Variance | 11.9 | |||
| Expected Short fall | (2.27) | |||
| Skewness | (0.44) | |||
| Kurtosis | 3.35 |
Additional Tools for BioCryst Stock Analysis
When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.